CRISPR Therapeutics AG (CRSP) Exchange Rate Effect (2015 - 2026)
CRISPR Therapeutics AG's (CRSP) quarterly Exchange Rate Effect came in at -$32000.0 in Q1 2026, down 178.05% year-on-year from $41000.0 in Q1 2025, and down 3300.0% quarter-over-quarter from $1000.0 in Q4 2025.
CRISPR Therapeutics AG (CRSP) Exchange Rate Effect (2015 - 2026) Analysis & Trends
CRISPR Therapeutics AG has disclosed Exchange Rate Effect across 12 years of filings, most recently posting -$32000.0 for Q1 2026.
- Exchange Rate Effect for Q1 2026 came in at -$32000.0, down 178.05% year-over-year; the trailing twelve-month figure through Mar 2026 was $22000.0 (down 29.03% YoY), and the FY2025 annual result was $95000.0, up 552.38% from the prior year.
- Exchange Rate Effect came in at -$32000.0 for Q1 2026 at CRISPR Therapeutics AG, down from $1000.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $115000.0 in Q4 2022 to a low of -$100000.0 in Q3 2022.
- The 5-year median for Exchange Rate Effect is $1000.0 (2025), against an average of $2058.8.
- Across the five-year window, Exchange Rate Effect sank 1460.0% in 2022 and soared 3900.0% in 2025, its largest moves.
- CRISPR Therapeutics AG's Exchange Rate Effect stood at $115000.0 in 2022, then plunged by 46.96% to $61000.0 in 2023, then sank by 242.62% to -$87000.0 in 2024, then surged by 101.15% to $1000.0 in 2025, then slumped by 3300.0% to -$32000.0 in 2026.
- The last three Exchange Rate Effect figures came in at -$32000.0 (Q1 2026), $1000.0 (Q4 2025), and -$27000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 8.68 Mn |
| 10 | CRISPR Therapeutics AG | 5.21 Bn | 2.76 Bn | - | -32,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -32,000.00 |
| Mar 31, 2026 | -32,000.00 |
| Dec 31, 2025 | 1,000.00 |
| Dec 31, 2025 | 1,000.00 |
| Sep 30, 2025 | -27,000.00 |
| Sep 30, 2025 | -27,000.00 |
| Jun 30, 2025 | 80,000.00 |
| Jun 30, 2025 | 80,000.00 |
| Mar 31, 2025 | 41,000.00 |
| Mar 31, 2025 | 41,000.00 |
| Dec 31, 2024 | -87,000.00 |
| Dec 31, 2024 | -87,000.00 |
| Sep 30, 2024 | 75,000.00 |
| Sep 30, 2024 | 75,000.00 |
| Jun 30, 2024 | 2,000.00 |
| Jun 30, 2024 | 2,000.00 |
| Mar 31, 2024 | -11,000.00 |
| Mar 31, 2024 | -11,000.00 |
| Dec 31, 2023 | 61,000.00 |
| Dec 31, 2023 | 61,000.00 |